Market capitalization of Haemonetics (HAE)

Market cap: A$5.80 Billion

As of October 2024 Haemonetics has a market cap of A$5.80 Billion. This makes Haemonetics the world's 3163th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

End of year Market Cap

End of Day market cap according to different sources

On Oct 17th, 2024 the market cap of Haemonetics was reported to be:

A$5.80 Billion

by Yahoo Finance

A$5.80 Billion

by CompaniesMarketCap

A$5.80 Billion

by Nasdaq

Market capitalization for similar companies or competitors

Name	Marketcap	Market cap differencediff.	Country
Thermo Fisher Scientific TMO	A$341.73 B	5,790.00%	🇺🇸 USA
Stryker Corporation SYK	A$204.65 B	3,427.25%	🇺🇸 USA
Becton Dickinson BDX	A$103.70 B	1,687.38%	🇺🇸 USA
Cerus CERS	A$0.45 B	-92.23%	🇺🇸 USA
Baxter BAX	A$27.91 B	381.11%	🇺🇸 USA
PerkinElmer PKI	A$21.58 B	271.96%	🇺🇸 USA
Johnson & Johnson JNJ	A$591.06 B	10,087.20%	🇺🇸 USA
Medtronic MDT	A$171.92 B	2,863.25%	🇮🇪 Ireland